Massachusetts Financial Services CO Horizon Therapeutics Public LTD CO Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020
SELL
$24.87 - $38.56 $2.56 Million - $3.97 Million
-102,897 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$25.43 - $36.67 $282,807 - $407,807
-11,121 Reduced 9.75%
102,897 $3.73 Million
Q3 2019

Nov 05, 2019
SELL
$23.0 - $27.97 $686,895 - $835,324
-29,865 Reduced 20.76%
114,018 $3.11 Million
Q2 2019

Aug 14, 2019
BUY
$22.81 - $28.48 $3.28 Million - $4.1 Million
143,883 New
143,883 $3.46 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email